Literature DB >> 7774712

Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau.

D A Latimer1, J M Gallo, S Lovestone, C C Miller, C H Reynolds, B Marquardt, S Stabel, J R Woodgett, B H Anderton.   

Abstract

A proportion of the microtubule-associated protein, tau, is in an elevated state of phosphorylation in foetal and adult brain whereas all of the tau in paired helical filaments, which are characteristic of Alzheimer's disease is hyperphosphorylated; it is important therefore to elucidate the mechanisms that regulate tau phosphorylation. Here we describe results that show that although MAP kinase can hyperphosphorylate tau in vitro, activation of MAP kinase in transformed fibroblasts does not result in hyperphosphorylation of transfected tau, whereas glycogen synthase kinase-3 beta (GSK-3 beta) when co-transfected with tau does result in tau hyperphosphorylation. The findings imply that GSK-3 beta may be a stronger candidate than MAP kinase for inducing tau hyperphosphorylation in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774712     DOI: 10.1016/0014-5793(95)00434-b

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities.

Authors:  F J Ekinci; T B Shea
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

Review 2.  Changes in the ageing brain in health and disease.

Authors:  B H Anderton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

3.  The order of exposure of tau to signal transduction kinases alters the generation of "AD-like" phosphoepitopes.

Authors:  T B Shea; C M Cressman
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

4.  Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.

Authors:  A Sengupta; Q Wu; I Grundke-Iqbal; K Iqbal; T J Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

5.  Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.

Authors:  M A Utton; A Vandecandelaere; U Wagner; C H Reynolds; G M Gibb; C C Miller; P M Bayley; B H Anderton
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

6.  tau kinases in the rat heat shock model: possible implications for Alzheimer disease.

Authors:  A Shanavas; S C Papasozomenos
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity.

Authors:  A Y Korneyev
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

8.  Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease.

Authors:  Jin-Jing Pei; Cheng-Xin Gong; Wen-Lin An; Bengt Winblad; Richard F Cowburn; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain.

Authors:  M Hoshi; A Takashima; K Noguchi; M Murayama; M Sato; S Kondo; Y Saitoh; K Ishiguro; T Hoshino; K Imahori
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

Review 10.  α-synuclein in the pathophysiology of Alzheimer's disease.

Authors:  Daniel Twohig; Henrietta M Nielsen
Journal:  Mol Neurodegener       Date:  2019-06-11       Impact factor: 14.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.